Therapeutic Combination of Nanoliposomal Safingol and Nanoliposomal Ceramide for Acute Myeloid Leukemia

Timothy J Brown^1,2, Aileen M. Garcia^3,4, Lindsey N Kissinger^1,2, Sriram S Shanmugavelandy⁴, Xujung Wang^1,2, Myles C Cabot⁵, Mark Kester^2,4, David F Claxton^1,2 and Brian M Barth^1,2,4*

¹Department of Medicine, Division of Hematology and Oncology, Penn State College of Medicine, Hershey, PA, USA

²Penn State Hershey Cancer Institute, Hershey, PA, USA

³Department of Biomedical Science, The Inter American University of Puerto Rico, Ponce, PR, USA

⁴Department of Pharmacology, Penn State College of Medicine, Hershey, PA, USA

⁵John Wayne Cancer Institute, Santa Monica, CA, USA

^*Corresponding Author: Brian M Barth, Ph.D, Department of Medicine, Division of Hematology and Oncology, Penn State Hershey Cancer Institute, Penn State College of Medicine, 500 University Drive, PO Box 850, CH46 Hershey, PA 17033, USA, Tel: 717-531-0003 (289457), Fax: (717)-531-5076 Email: ,